Daxor Corp (DXR) |
|
11.4579 0.048 (0.42%)
|
03-05 08:44 |
|
Open: |
11.6296 |
Pre. Close: |
11.41 |
|
High:
|
11.6296 |
Low:
|
11.26 |
|
Volume:
|
3,305 |
Market Cap:
|
46M |
|
|
|
|
Daxor Corp. is a biotechnology company which develops and manufactures BVA-100 blood volume analyzer, an instrument that measures human blood volume. The company is headquartered in New York, New York and currently employs 37 full-time employees. The firm focuses on the development of the Blood Volume Analyzer (BVA) -100, an instrument that rapidly and accurately measures human blood volume. The Company’s instrument is used in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit.The Company also owns the Daxor Oak Ridge Operations (DORO) facility in Oak Ridge, Tennessee. The semi-automated BVA provides blood volume measurements in human body for diagnosis and treatment in a range of medical and surgical conditions. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
11.635 - 11.706 |
11.706 - 11.773 |
|
Low:
|
11.096 - 11.178 |
11.178 - 11.256 |
|
Close:
|
11.334 - 11.455 |
11.455 - 11.571 |
|
Technical analysis |
as of: 2021-03-05 8:09:46 AM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 17.71  One year: 20.53 |
| Support: |
Support1: 11.26 Support2: 9.37 |
| Resistance: |
Resistance1: 15.17 Resistance2: 17.58 |
| Pivot: |
12.38 |
| Moving Average: |
MA(5): 11.54 MA(20): 12.71
MA(100): 13.32 MA(250): 14.37 |
| MACD: |
MACD(12,26): -0.48 Signal(9): -0.31 |
| Stochastic oscillator: |
%K(14,3): 4.36 %D(3): 5.25 |
| RSI: |
RSI(14): 32.99 |
| 52-week: |
High: 24.08 Low: 8.47 Change(%): -5.9 |
| Average Vol(K): |
3-Month: 773 10-Days: 152 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.DXR has closed above bottom band by 24.9%. Bollinger Bands are 135.9% wider than normal. The large width of the bands suggest high volatility as compared to DXR's normal range. The bands have been in this wide range for 7 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Thu, 04 Mar 2021
Daxor to Present at the H.C. Wainwright Global Life Sciences Conference - GlobeNewswire
Fri, 26 Feb 2021
A Look At The Fair Value Of Daxor Corporation (NYSEMKT:DXR) - Yahoo Finance
Fri, 26 Feb 2021
Daxor Corporation Announces $0.48 Per Share NAV Increase and Files Annual Report for Fiscal 2020 - GlobeNewswire
Tue, 09 Feb 2021
Maxim Group Maintains a Buy Rating on Daxor (DXR) - Smarter Analyst
Fri, 05 Feb 2021
Is Daxor Corporation (DXR) Stock Worth a Buy Friday? - InvestorsObserver
Fri, 05 Feb 2021
DAXOR CORPORATION AWARDED GRANT FROM THE CENTER FOR ADVANCING POINT OF CARE TECHNOLOGIES (CAPCAT) TO DEVELOP A POINT-OF-CARE BLOOD VOLUME ANALYZER - GlobeNewswire
|
Financial Analysis |
| Growth |
n/a |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
n/a |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Underperform |
Price to Earnings: |
Underperform |
| Return on Equity: |
Underperform |
Debt to Equity: |
Neutral |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: AMEX |
| Sector: Financial Services |
| Industry: Asset Management |
| Shares Out. (M) |
4 |
| Shares Float (M) |
1 |
|
% Held by Insiders
|
78.62 |
|
% Held by Institutions
|
1.08 |
|
Shares Short (K)
|
11 |
|
Shares Short P. Month (K)
|
12 |
Stock Financials |
|
EPS
|
-1.150 |
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
2.870 |
|
Profit Margin
|
|
|
Operating Margin
|
-37.46 |
|
Return on Assets (ttm)
|
-0.4 |
|
Return on Equity (ttm)
|
-36.2 |
|
Qtrly Rev. Growth
|
-38.3 |
|
Gross Profit (p.s.)
|
0.098 |
|
Sales Per Share
|
0.079 |
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
2 |
|
Levered Free Cash Flow (M)
|
-2 |
Stock Valuations |
|
PE Ratio
|
-9.96 |
|
PEG Ratio
|
|
|
Price to Book value
|
3.99 |
|
Price to Sales
|
145.58 |
|
Price to Cash Flow
|
25.91 |
Stock Dividends |
|
Dividend
|
0.030 |
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
2018-01-11 |
|
Ex-Dividend Date
|
2018-01-04 |
|
7 Binary Options
|
|
Your Ad Here
|
|
